A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising
about
HPV vaccination's second act: promotion, competition, and compulsionMedia, messages, and medication: strategies to reconcile what patients hear, what they want, and what they need from medicationsThe Evolution of Self-Reported Urinary and Sexual Dysfunction over the Last Two Decades: Implications for Comparative Effectiveness Research.An academic-marketing collaborative to promote depression care: a tale of two cultures.The rise of digital direct-to-consumer advertising?: Comparison of direct-to-consumer advertising expenditure trends from publicly available data sources and global policy implications.Mind the gap: understanding the effects of pharmaceutical direct-to-consumer advertisingNow you see it. Now you don't: fair balance and adequate provision in advertisements for drugs before and after the switch from prescription to over-the-counter.Direct-to-Consumer Pharmaceutical Advertising: Therapeutic or Toxic?The role of informatics in promoting patient-centered care.Trends in exposure to televised prescription drug advertising, 2003-2011.Prevalence and Global Health implications of social media in direct-to-consumer drug advertising.Direct-to-consumer Marketing to People with HemophiliaAccuracy of marketing claims by providers of stereotactic radiation therapy.Direct-to-consumer television advertising exposure, diagnosis with high cholesterol, and statin useIllicit use of prescription stimulants in a college student sample: a theory-guided analysis.Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical StudiesMeasuring Exposure to Direct-to-Consumer Advertising-A Validation Study in the Context of Cancer-Related Treatment AdvertisingSeniors' perceptions of prescription drug advertisements: a pilot study of the potential impact on informed decision making.The continued social transformation of the medical profession.Governmental oversight of prescribing medications: history of the US Food and Drug Administration and prescriptive authority.Responding to requests of families for unproven interventions in neurodevelopmental disorders: hyperbaric oxygen "treatment" and stem cell "therapy" in cerebral palsy.Mixed Messages, Mixed Outcomes: Exposure to Direct-to-Consumer Advertising for Statin Drugs is Associated with More Frequent Visits to Fast Food Restaurants and Exercise.Effects of Direct-To-Consumer Advertising on Patient Prescription Requests and Physician Prescribing: A Systematic Review of Psychiatry-Relevant Studies.Prescription drug advertising, disease knowledge, and older adults' optimistic bias about the future risk of Alzheimer's disease.Then and Now: Examining How Consumer Communication and Attitudes of Direct-to-Consumer Pharmaceutical Advertising Have Changed in the Last Decade.Fair balance in direct-to-consumer antidepressant print and television advertising, 1995-2007.Effects of Televised Direct-to-Consumer Advertising for Varenicline on Prescription Dispensing in the United States, 2006-2009.The Conundrum of Online Prescription Drug Promotion Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".An analysis of online messages about probiotics.Reforming direct-to-consumer advertising.Stem cells, dot-com.Communicating Risk Information in Direct-to-Consumer Prescription Drug Television Ads: A Content Analysis."When diet and exercise are not enough": an examination of lifestyle change inefficacy claims in direct-to-consumer advertising.Pre-market approval and post-market direct-to-consumer advertising of medical devices in Australia: a case study of breast cancer screening and diagnostic devices.The ethics of advertising for health care services.Primary care physicians report high trust in and usefulness of the Stockholm drug and therapeutic committee's list of recommended essential medicines (the 'Wise List').'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.Regulating the advertising and promotion of stem cell therapies.Medicalization and overdiagnosis: different but alike.Direct-to-Consumer Prescription Medicine Advertising and Seniors' Knowledge of Alzheimer's Disease.
P2860
Q24612957-BB085F61-783A-49CE-BBCE-47FB165176CAQ27013553-C7536085-63B5-4D85-887C-6F7DF506A1DBQ27311513-AC0CE23A-63A1-49DD-AFBF-3B4DC0EC3ED0Q30406312-F1DCB09E-C5EA-4DC9-840E-B6C90D25BA61Q30974238-DC67AFE3-2692-4AB7-AC5E-C5A36FDF746CQ33652458-5DA2B1FA-52E8-46C9-BA07-B0CDF6EB5DBBQ33957094-8E4A3141-6EE8-421D-BB87-1F62CDB6840AQ34255491-7FB1F5C0-8EB6-4C1F-B883-6AF083BE69B7Q35137693-4EA5F480-7612-4CB4-9DD6-67E73B2C4566Q35516746-C0961340-43C2-4D22-923C-4C31DA9F73DCQ35567706-F79709BC-57B0-4F60-8950-8A33E1D8A4E9Q36051468-295316D7-6936-4FB9-9C61-DC25762EAA98Q36534796-401F75B2-56EF-4693-9AAA-43DC21F28BC6Q36927407-D08FE240-1964-4DCF-987A-94F983CB5D3DQ37164800-9EEFF00F-2EDC-4F4B-B403-E2663A5C60C0Q37184695-01A60315-995B-4041-A21A-9C74D6E2209FQ37672317-DE90B1FC-9EDF-4831-ACD4-75AFB48E56D3Q37686229-91D0898E-C074-467A-B7C0-4E171D6D4E8EQ37799914-DCDBF0D4-5E35-48B5-9532-DAB48AC788CDQ37871037-437B4F43-A2A5-4785-9F87-4CA495964518Q37996969-56EEE968-D9A9-477B-B87E-E38E24063395Q38840755-1370FE5B-DE6E-463B-B81A-37BA21CAE563Q38955012-74DA212F-8B75-4FE1-92A2-04660C87E5B7Q38964947-05F0EF5A-9650-4190-8578-DF69BAEF3646Q39315585-AAA77CAD-68B8-4343-9DEA-A5F3F8D4B0B3Q39684091-FBE098A7-6F47-4E18-AB3F-568BA293C211Q40523144-EB02262C-9E6C-4494-BA80-8257E6CB78E1Q41956461-10947FB8-0579-42D4-87B4-81A6E3877942Q43008544-67278AC5-7FE4-40CE-9712-8957B4E21195Q43920556-C515ACDF-286C-4A28-B42F-562EDBEFA9BDQ43957462-799CFF8B-2F46-46AD-B588-53111E4C81CBQ44339499-778D9C90-BD26-471D-B04D-8084E781F902Q44808297-8BA1471F-A5E4-4B23-AEB1-17B7C0872218Q46873126-5A9E6C62-B2A8-49C8-862E-0F5D32D9FBCEQ48084161-D23B54BB-3ED8-4488-A6E4-A039354CBC61Q48141652-BA46F1AA-EBCA-4B08-A916-98F156D70557Q48156454-49A02FB2-95EB-4A3A-A3BE-E662968E151CQ50122051-4DF24FF4-04A5-49CD-8C06-EBB12916F859Q50229427-4453716C-56A2-4080-88C7-4AB8EE2ED606Q53260973-0BF169A4-B0CF-49AB-9ACC-B458AAA8041A
P2860
A decade of controversy: balancing policy with evidence in the regulation of prescription drug advertising
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A decade of controversy: balan ...... prescription drug advertising
@ast
A decade of controversy: balan ...... prescription drug advertising
@en
A decade of controversy: balan ...... prescription drug advertising
@nl
type
label
A decade of controversy: balan ...... prescription drug advertising
@ast
A decade of controversy: balan ...... prescription drug advertising
@en
A decade of controversy: balan ...... prescription drug advertising
@nl
prefLabel
A decade of controversy: balan ...... prescription drug advertising
@ast
A decade of controversy: balan ...... prescription drug advertising
@en
A decade of controversy: balan ...... prescription drug advertising
@nl
P2093
P2860
P3181
P356
P1476
A decade of controversy: balan ...... prescription drug advertising
@en
P2093
David Grande
Derjung M Tarn
Dominick L Frosch
P2860
P3181
P356
10.2105/AJPH.2008.153767
P407
P577
2010-01-01T00:00:00Z